Centre for Online Health, The University of Queensland, Brisbane, Australia; Centre for Health Services Research, The University of Queensland, Brisbane, Australia; Pharmacy Department, Princess Alexandra Hospital, Brisbane, Australia.
Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.
Value Health. 2021 Feb;24(2):291-302. doi: 10.1016/j.jval.2020.09.006. Epub 2020 Oct 24.
Asthma is one of the most common major noncommunicable diseases in the world and affects individuals of all ages. Medication is used to achieve and maintain quality of life (QOL) for people with asthma. Telehealth interventions offer optimized and personalized symptom monitoring with timely treatment adjustment and the potential to increase medication adherence for individuals with asthma. This study examines and synthesizes the available data on the change in the QOL for patients with asthma who use interactive telehealth interventions, and identifies the most effective telehealth modalities used for intervention in this area.
Literature searches were conducted in 5 databases in November 2018 for studies measuring a change in QOL for patients with asthma. Study QOL outcomes, where possible, were pooled in a meta-analysis.
Seventeen publications (describing 16 studies) comprising 2015 patients were included. Based on a meta-analysis, interactive telehealth interventions can improve QOL outcomes for people living with asthma, although the improved effects may be small: web portals (0.51, 95% confidence interval [CI] -0.00 to 1.03), interactive smartphone apps (0.30, 95% CI -0.16 to 0.76) and remote monitoring (standardized mean difference 0.20, 95% CI -0.11 to 0.52). Intervention delivery modalities identified include interactive web portals, smartphone apps, and remote monitoring programs.
The findings provide a comprehensive overview of the available literature on interactive telehealth interventions, including interactive web portals, smartphone apps, and remote monitoring programs. These findings demonstrated that a positive change in QOL can be attributed to these interventions and provide evidence for the implementation of telehealth interventions for individuals with asthma.
哮喘是世界上最常见的重大非传染性疾病之一,影响各个年龄段的人群。药物治疗用于提高哮喘患者的生活质量(QOL)。远程医疗干预措施通过优化和个性化的症状监测,及时调整治疗方案,提高哮喘患者的药物依从性。本研究旨在分析和综合现有的关于使用互动式远程医疗干预措施的哮喘患者 QOL 变化的数据,并确定该领域最有效的远程医疗干预模式。
2018 年 11 月,我们在 5 个数据库中进行了文献检索,以评估哮喘患者 QOL 变化的研究。尽可能对研究的 QOL 结果进行了荟萃分析。
共纳入 17 篇文献(描述了 16 项研究),共纳入 2015 名患者。基于荟萃分析,互动式远程医疗干预措施可以改善哮喘患者的 QOL 结果,但改善效果可能较小:网络门户(0.51,95%置信区间[CI] -0.00 至 1.03)、互动智能手机应用程序(0.30,95%CI -0.16 至 0.76)和远程监测(标准化均数差 0.20,95%CI -0.11 至 0.52)。确定的干预传递模式包括互动式网络门户、智能手机应用程序和远程监测程序。
这些发现提供了一个关于互动式远程医疗干预措施的全面综述,包括互动式网络门户、智能手机应用程序和远程监测程序。这些发现表明,这些干预措施可以使 QOL 发生积极的变化,为哮喘患者实施远程医疗干预措施提供了证据。